On the recordMarch 12, 2019
I am worried that if we do not start to address the barriers to biosimilar entry sooner than later patients will not be able to realize the benefits.
Source
congress.govI am worried that if we do not start to address the barriers to biosimilar entry sooner than later patients will not be able to realize the benefits.
Concern about delays in biosimilar market entry affecting patient access.
Share
More from Tony Cárdenas
The fact remains that for far too many American households, in both Democratic and Republican districts, the monthly cost of an internet connection is not affordable enough to them.
I would like to thank the witnesses for joining us and providing your expertise on these important issues.
It is important to me that our spectrum policy in this country keeps this in mind and we prioritize intense mobile wireless competition.